| Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619) |
|---|
| 05/06/2009 | CN101426788A Substituted pyrazinone derivatives for use as a medicine |
| 05/06/2009 | CN101423499A Method for preparing high purity 4,6-dimethoxy-2-((phenoxy carbonyl)amido)-pyrimidine |
| 05/06/2009 | CN101423498A Method for preparing 4,6-diclor-5-fluoropyrimidine compound |
| 05/06/2009 | CN101423481A Diketohydrazine derivative compound and medicine containing the compound as active ingredient |
| 05/06/2009 | CN100484934C Processes for preparing substituted pyrimidines and pyrimidine derivatives as inhibitors of protein kinase |
| 05/05/2009 | US7528143 JAK family of protein tyrosine kinases inhibitors; N4-(4-Methoxy-phenyl)-N2-[4-(2-pyrrolidin-1-yl-ethoxy)-phenyl]-pyrimidine-2,4-diamine; angiogenic-associated disorders including solid tumors and cancer, eye disease, inflammation, psoriasis, viral infection; antiproliferative agents |
| 05/05/2009 | US7528137 Compounds, compositions, and methods |
| 05/05/2009 | US7528134 Acetamides and benzamides that are useful in treating sexual dysfunction |
| 05/05/2009 | US7528133 Use of thiazolidinediones derivatives for preventing uterine contractions in premature labour or lactation |
| 05/05/2009 | US7528121 Aurora kinases inhibitors; antiproliferative agents; specially for solid and haematological tumors; 2-[[3-({4-[(5-{2-[(3-fluorophenyl)amino]-2-oxoethyl}-1H-pyrazol-3-yl)amino]-quinazolin-7-yl}oxy)propyl](ethyl)amino]ethyl dihydrogen phosphate |
| 05/05/2009 | CA2513549C Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions |
| 05/05/2009 | CA2386230C Modulators of cytokine mediated signalling pathways and integrin .alpha.v.beta.3 receptor antagonists for combination therapy |
| 05/05/2009 | CA2149298C Flk-1 is a receptor for vascular endothelial growth factor |
| 04/30/2009 | WO2009055548A1 Arylindenopyrimidines and their use as adenosine a2a receptor antagonists |
| 04/30/2009 | WO2009055308A1 Arylindenopyrimidines and their use as adenosine a2a receptor antagonists |
| 04/30/2009 | WO2009055299A1 Substituted pyrimidine-5-carboxamide and 5-carboxylic ester kinase inhibitors |
| 04/30/2009 | WO2009054253A1 Organic electroluminescent device, display device and illuminating device |
| 04/30/2009 | WO2009053748A2 Novel crystalline forms |
| 04/30/2009 | WO2009052719A1 Preparation methods of azoxystrobin and its analogs |
| 04/30/2009 | WO2009007441A3 Crystalline form of (e) 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2 pyrimidinyl]amino]benzonitrile |
| 04/30/2009 | WO2008140553A4 Mapk/erk kinase inhibitors |
| 04/30/2009 | US20090111984 Novel Method For Producing Pyrimidine Compound |
| 04/30/2009 | US20090111839 Process for Preparing Amorphous Rosuvastatin Calcium of Impurities |
| 04/30/2009 | US20090111838 6-arylamino-5-cyano-4-pyrimidinones as pde9a inhibitors |
| 04/30/2009 | US20090111837 Use of pde7 inhibitors for the treatment of neuropathic pain |
| 04/30/2009 | US20090111834 Novel flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereof |
| 04/30/2009 | US20090111795 Multimers of Heterocyclic Compounds and Their Use |
| 04/30/2009 | US20090111772 Formulation of quinazoline based egfr inhibitors containing a zinc binding moiety |
| 04/30/2009 | CA2703230A1 Novel crystalline forms |
| 04/29/2009 | EP2053048A1 Chemical in situ sulphonating process |
| 04/29/2009 | EP1771421B1 N-hydroxyamide derivatives and use thereof |
| 04/29/2009 | EP1446379B1 Aryl aniline beta-2 adrenergic receptor agonists |
| 04/29/2009 | EP1345910B1 Quinazoline derivatives, medicaments containing said compounds, their utilization and method for the production thereof |
| 04/29/2009 | CN101421253A Quinazolin-4-one derivatives, process for their preparation and pharmaceutical compositions containing them |
| 04/29/2009 | CN101421252A 2,6-substituted-4-monosubstituted amino-pyrimidine as prostaglandin D2 receptor antagonists |
| 04/29/2009 | CN101421251A 4,5-diphenyl-pyrimidinyl-amino substituted carboxylic acids, method for the production and use thereof as medicaments |
| 04/29/2009 | CN101421250A 4-aryl-2-amino-pyrimidines or 4-aryl-2-aminoalkyl-pyrimidines as jak-2 modulators and pharmaceutical compositions containing them |
| 04/29/2009 | CN101421249A 4,5-diphenyl-pyrimidinyl-oxy or -mercapto substituted carboxylic acids, method for the production and use thereof as medicaments |
| 04/29/2009 | CN101421248A 4,5-diphenyl-pyrimidinyl substituted carboxylic acids, method for the production and use thereof as medicaments |
| 04/29/2009 | CN101421243A Aryloxyethylamine compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor |
| 04/29/2009 | CN101421230A Novel phenyl-propargylether derivatives |
| 04/29/2009 | CN101420985A Test agent for diagnosing dyspepsia |
| 04/29/2009 | CN101417964A Use of compounds for the elevation of pyruvate dehydrogenase activity |
| 04/29/2009 | CN100482648C New uracils having a herbicidal activity |
| 04/28/2009 | US7524969 Cardiovascular disorders; anticancer agents; antidiabetic agents; dietetics |
| 04/28/2009 | US7524957 Compounds effecting glucokinase |
| 04/28/2009 | US7524955 Process for the preparation of pyrimidine compounds |
| 04/28/2009 | US7524874 Vanilloid receptor ligands and their use in treatments |
| 04/28/2009 | US7524873 Substituted N-phenylmethyl ethanamines; N-((6-(methyloxy)-4'-(trifluoromethyl)-1,1'-biphenyl-3-yl)methyl)-1-(1-naphthalenyl)ethanamine; parathyroid hormone inhibitors; antisecretory agents; osteoporosis |
| 04/28/2009 | US7524871 Thrombin inhibitors |
| 04/28/2009 | US7524853 Cyclohexylthiophenepyrimidinone, cyclohexylpyrrolylpyrimidinone or cyclohexylfuranylpyrimidinone compounds for use in the treatment of a steroid hormone dependent diseases; inhibitor of 17 beta -hydroxysteroid dehydrogenase enzymes |
| 04/28/2009 | US7524849 5-arylpyrimidines as anticancer agents |
| 04/28/2009 | US7524843 N-methyl-N-(1-methyl-1H-indol-3-ylmethyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamide as an enzyme inhibitor for both Fab I and Fab K which are used in the biosynthesis of fatty acids; enoyl-acyl-carrier protein renamed Fab 1; bactericides; fungicides; Staphylococcus aureus; antibiotics |
| 04/28/2009 | CA2499330C New spirocondensed quinazolinones and their use as phosphodiesterase inhibitors |
| 04/28/2009 | CA2375259C Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them |
| 04/28/2009 | CA2361716C Method of preparing alkylated salicylamides |
| 04/28/2009 | CA2339765C Compounds and compositions for delivering active agents |
| 04/28/2009 | CA2227762C Substituted aminouracils |
| 04/23/2009 | WO2009052078A1 Ccr10 antagonists |
| 04/23/2009 | WO2009051782A1 Deuterated etravirine |
| 04/23/2009 | WO2009051112A1 Amide compounds and use of the same |
| 04/23/2009 | WO2009050506A2 Combination 059 |
| 04/23/2009 | WO2009050120A1 Method for producing sulfonic acid diamides |
| 04/23/2009 | WO2009049884A1 Phenobarbital derivatives useful in immunoassay |
| 04/23/2009 | WO2009001060A3 Use of compounds for preparing anti-tuberculosis agents |
| 04/23/2009 | WO2008131501A3 New anti-viral nucleoside analogs |
| 04/23/2009 | WO2006130629A3 Daptomycin for the treatment of biofilm and catheter salvage |
| 04/23/2009 | WO2006028524A3 Compositions and treatments for inhibiting kinase and/or hmg-coa reductase |
| 04/23/2009 | US20090105478 Novel compounds |
| 04/23/2009 | US20090105477 Quinazoline Protein Tyrosine Phosphatase Inhibitors |
| 04/23/2009 | US20090105447 Novel Polymers |
| 04/23/2009 | US20090105287 Inhibitors of Dihydrofolate Reductase With Antibacterial Antiprotozoal, Antifungal and Anticancer Properties |
| 04/23/2009 | US20090105283 3-HYDROQUINAZOLIN-4-ONE DERIVATIVES FOR USE AS STEAROYL CoA DESATURASE INHIBITORS |
| 04/23/2009 | US20090105280 Novel Aromatic Nitro Compounds |
| 04/23/2009 | US20090105279 Tetrahydrofuro[2,3-b]furyl carbamates containing an (oxy)hydrazide group; these compounds target the HIV protease in both wild type and mutant strains of HIV. |
| 04/23/2009 | US20090105278 Selective inhibitors of human corticosteroid syntheses |
| 04/23/2009 | US20090105269 Multifunctional Compounds and Methods of Use Thereof |
| 04/23/2009 | US20090105268 Dihydropyrimidone Multimers and Their Use as Human Neutrophil, Elastase Inhibitors |
| 04/23/2009 | US20090105248 3-monosubstituted tropane derivatives as nociceptin receptor ligands |
| 04/23/2009 | US20090105232 Cyclohexyl or piperidinyl carboxamide antibiotic derivatives |
| 04/23/2009 | US20090105230 Anti-inflammatory medicaments |
| 04/23/2009 | US20090105211 Inhibitors of hedgehog pathway |
| 04/23/2009 | US20090105147 Deuterated etravirine |
| 04/23/2009 | US20090105072 2-(Pyridin-2-Yl)-Pyrimidines for Use as Fungicides |
| 04/23/2009 | US20090104713 Phenobarbital derivatives useful in immunoassay |
| 04/23/2009 | US20090102370 Compound, electroluminescent element containing the same, illuminating device and display device |
| 04/23/2009 | CA2702674A1 Heteroaryl compounds and uses thereof |
| 04/23/2009 | CA2702469A1 Ccr10 antagonists |
| 04/23/2009 | CA2702315A1 Combination 059 |
| 04/23/2009 | CA2695460A1 Phenobarbital derivatives useful in immunoassay |
| 04/22/2009 | EP2050744A1 Quinazoline derivatives as angiogenesis inhibitors |
| 04/22/2009 | EP2050739A1 Quinazoline derivative |
| 04/22/2009 | EP2049503A1 Quinazoline and pyridopyrimidine derivatives as p38 kinase inhibitors |
| 04/22/2009 | EP2049502A1 2,4-substituted quinazolines as lipid kinase inhibitors |
| 04/22/2009 | EP2049501A1 Hydroxylated and methoxylated cyclopenta [d] pyrimidines as akt protein kinase inhibitors |
| 04/22/2009 | EP2049500A1 Cyclopenta [d] pyrimidines as akt protein kinase inhibitors |
| 04/22/2009 | EP2049499A1 Labelling of fusion proteins with synthetic probes |
| 04/22/2009 | EP2049498A1 Pyrimidine compounds for combating pathogenic fungi and cancer |
| 04/22/2009 | EP2049497A2 Pyrimidine derivatives as hsp90 inhibitors |
| 04/22/2009 | EP2049491A1 Heteroaryl compounds useful as inhibitors of e1 activating enzymes |